Combined treatment with serotonin reuptake selective inhibitors in depression (II). Aspects concerning tolerance and toxicity in clinical practice

Author： Loza A.A.S.   Valverde J.I.F.   Montes M.J.R..   Martiacute nez M.L.D.   Caballero J.L.V..   Docio E.Q.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 292-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Depression in Acute Coronary Syndromes with Selective Serotonin Reuptake Inhibitors

By van Melle Joost P.  

Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. : 2095-2107

Adis International

Access to resources Recommend Favorite

Risks and Benefits of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression

By Mourilhe P.   Stokes P.E.  

Drug Safety, Vol. 18, Iss. 1, 1998-01 ,pp. : 57-82

Adis International

Access to resources Recommend Favorite

Dopamine receptor binding in major depression: changes before and after treatment with selective serotonin reuptake inhibitors

By Klimke A.   Larisch R.   Janz A.   Vosberg H.   Muuml ller-Gauml rtner H.W.   Gaebel W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 300-300

Elsevier

Access to resources Recommend Favorite

Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression in Children and Adolescents: Practitioner Review

By Sharp Susan C.   Hellings Jessica A.  

Clinical Drug Investigation, Vol. 26, Iss. 5, 2006-01 ,pp. : 247-255

Adis International

Access to resources Recommend Favorite

Formulary Restriction of Selective Serotonin Reuptake Inhibitors for Depression: Potential Pitfalls

By Hensley P.L.   Nurnberg H.G.  

PharmacoEconomics, Vol. 19, Iss. 10, 2001-01 ,pp. : 973-982

Adis International

Access to resources Recommend Favorite